LANIER BIOTHERAPEUTICS
Lanier Biotherapeutics develops antibody treatments for specialty diseases. The company was founded in 2021 and is based in Bogart, Georgia.
LANIER BIOTHERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2021-01-01
Address:
Bogart, Georgia, United States
Country:
United States
Website Url:
http://www.lanierbio.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API WordPress Content Delivery Network Font Awesome Wordpress Plugins Mobile Non Scaleable Content Sitelinks Search Box Euro
Similar Organizations
Ocugenix
Ocugenix is a therapeutics company that develops treatments for angio-fibrotic diseases of the eye.
Current Employees Featured
Founder
Official Site Inspections
http://www.lanierbio.com
- Host name: 161.0.153.160.host.secureserver.net
- IP address: 160.153.0.161
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Lanier Biotherapeutics"
Lanier Biotherapeutics: We discover and develop antibody โฆ
Lanier Biotherapeutics targets four major verticals: Multi-functional Retina, Type 2 Inflammation, Dermatology, and ImmunoOncology.See details»
Lanier Biotherapeutics - Crunchbase Company Profile โฆ
Lanier Biotherapeutics develops antibody treatments for specialty diseases. The company was founded in 2021 and is based in Bogart, Georgia.See details»
Business Development - Lanier Biotherapeutics
July 9, 2021. Molecular Templates, Inc. Announces Dosing of First Subject in Phase 1 Study of MT-6402 in PD-L1-Positive Solid TumorsSee details»
Lanier Biotherapeutics - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for Lanier Biotherapeutics. Use the PitchBook Platform to explore the full profile.See details»
Company Information - RocketReach
Lanier Biotherapeutics was founded by combining the businesses of Biophtha and Abeome, to further develop an existing first-in-class biologics portfolio for specialty disease, with the โฆSee details»
Lanier Biotherapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Lanierbio.com. Private Company | 2021 | United States | lanierbio.com. Last update 23 Jan 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. ...See details»
Lanier Biotherapeutics - VentureRadar
"Lanier Biotherapeutics was founded by combining the businesses of Biophtha and Abeome, to further develop an existing first-in-class biologics portfolio for specialty disease, with the โฆSee details»
Investors - Lanier Biotherapeutics
If you are interested in further exploring as an investor, please contact us. Connect With Us. Corporate OfficeSee details»
Lanier Biotherapeutics - Overview, News & Similar companies
Www.lanierbio.com. Revenue <$5 Million. Industry Drug Stores & Pharmacies Retail . Recent News & Media. No recent news or media. Overview ; Org Chart ; Who is Lanier โฆSee details»
Lanier Biotherapeutics - Products, Competitors, Financials, โฆ
Lanier Biotherapeutics is a biotechnology company focused on the discovery and development of antibody treatments in the healthcare sector. Use the CB Insights Platform to explore Lanier โฆSee details»
Newly Formed Lanier Biotherapeutics Enters into License โฆ
Oct 5, 2021 Agreement Marks the Official Launch of Lanier, a Georgia-Based Biopharmaceutical Company Developing a Robust Portfolio of First-in-Class Antibody CandidatesBOGART, Ga., โฆSee details»
Lanier Biotherapeutics, Inc. (Lanier Biotherapeutics, Inc.) - ่ฏ็ฉ็ฎก โฆ
Lanierbio.com. ๆดๆฐไบ๏ผ2025-01-23. ... APPENDIX 2: LIST OF COMPANIES AND ORGANIZATION Companies Mentioned 2BScientific 3SBio AAT Bioquest Ab Initio โฆSee details»
Newly Formed Lanier Biotherapeutics Enters into License
Oct 5, 2021 For more information, please visit www.lanierbio.com. Contact: Stephen Kilmer Lanier Biotherapeutics Inc. Investor & Public Relations (646) 274-3580 โฆSee details»
Newly Formed Lanier Biotherapeutics Enters into License
Oct 5, 2021 Lanierโs lead developments programs include LNR 653.1, a fully humanized anti-VEGF / IL-17A multifunctional antibody for the treatment of retinal neovascularization diseases โฆSee details»
Contact - Lanier Biotherapeutics
150 Technology Parkway Room #130 Peachtree Corners, GA 30092. Twitter Twitter. Name E-mailSee details»
Lanier Biotherapeutics to develop first-in-class biologics portfolio ...
Oct 26, 2021 Recently launched Lanier Biotherapeutics is developing specialty biologic treatments for indications in multifunctional retina, dermatology and Type 2 inflammation โฆSee details»
Top Dermatology start-ups - VentureRadar
Clinikally. Privately Held. Founded 2021. India. Clinikally is India's first multi-condition health platform that provides Telehealth, AI-enabled treatment plans, and doctor-prescribed products โฆSee details»
Lanier Biotherapeutics Announces Issuance of U.S. Patent for IL-25 ...
Nov 14, 2022 For more information, please visit www.lanierbio.com. Contact: Stephen Kilmer Lanier Biotherapeutics Inc. Investor & Public Relations (646) 274-3580 โฆSee details»
Team Archive - Lanier Biotherapeutics
Twitter page opens in new window Linkedin page opens in new windowSee details»
Simplification for success: Rewiring the biopharma operating model
Mar 21, 2025 Thirty-seven of them expect their organization to pursue a simplification effort over the next 12 months. Thirty-two respondents say they believe they need a significantly different โฆSee details»